NIH will use Abbott’s neuromodulation technologies to explore the devices’ applications for chronic pain and progressive movement disorders, like Parkinson’s disease.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,